Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
Peroxisome proliferator-activated receptor-γ (PPARγ) agonists such as rosiglitazone and pioglitazone are used to improve insulin sensitivity in patients with diabetes mellitus. However, thiazolidinediones induce fluid retention, edema, and sometimes precipitate or exacerbate heart failure in a subse...
Saved in:
Main Authors: | Jerzy Bełtowski, Jolanta Rachańczyk, Mirosław Włodarczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2013/628628 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
by: Tianxin Yang, et al.
Published: (2008-01-01) -
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
by: Shoko Horita, et al.
Published: (2015-01-01) -
Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease
by: María José Pérez, et al.
Published: (2015-01-01) -
Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01) -
Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)